Your browser is no longer supported. Please, upgrade your browser.
Settings
RYTM Rhythm Pharmaceuticals, Inc. daily Stock Chart
RYTM [NASD]
Rhythm Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-3.84 Insider Own1.30% Shs Outstand44.05M Perf Week-4.50%
Market Cap915.83M Forward P/E- EPS next Y-2.46 Insider Trans-57.48% Shs Float40.92M Perf Month-1.32%
Income-145.90M PEG- EPS next Q-0.83 Inst Own94.70% Short Float4.12% Perf Quarter24.76%
Sales- P/S- EPS this Y-61.70% Inst Trans-3.40% Short Ratio7.97 Perf Half Y-3.98%
Book/sh5.75 P/B3.65 EPS next Y24.80% ROA-60.10% Target Price32.88 Perf Year1.69%
Cash/sh5.91 P/C3.56 EPS next 5Y16.10% ROE-67.50% 52W Range12.99 - 25.86 Perf YTD-8.49%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-18.75% Beta-
Dividend %- Quick Ratio15.10 Sales past 5Y- Gross Margin- 52W Low61.74% ATR1.18
Employees70 Current Ratio15.10 Sales Q/Q- Oper. Margin- RSI (14)46.09 Volatility3.97% 5.73%
OptionableYes Debt/Eq0.00 EPS Q/Q7.90% Profit Margin- Rel Volume0.37 Prev Close21.90
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume211.19K Price21.01
Recom1.70 SMA20-5.06% SMA501.79% SMA2004.96% Volume78,845 Change-4.06%
Jan-08-20Initiated Goldman Sell $18
Jul-12-19Upgrade Stifel Hold → Buy $34
Jul-08-19Initiated Canaccord Genuity Buy $35
Mar-13-19Initiated Ladenburg Thalmann Buy $43
Sep-07-18Resumed Morgan Stanley Overweight
Jun-25-18Reiterated Needham Buy $36 → $42
Jun-15-18Reiterated Needham Buy $32 → $36
Oct-30-17Initiated Needham Buy $32
Oct-30-17Initiated BofA/Merrill Buy $30
Jul-01-20 08:00AM  
08:00AM  
Jun-26-20 11:20AM  
May-26-20 08:00AM  
May-13-20 09:00AM  
May-05-20 08:00AM  
May-04-20 08:00AM  
Apr-21-20 12:14PM  
Apr-07-20 08:00AM  
Mar-30-20 08:00AM  
07:55AM  
Mar-18-20 08:00AM  
Mar-02-20 08:00AM  
Feb-25-20 08:00AM  
Jan-07-20 01:11PM  
07:57AM  
Jan-06-20 04:15PM  
Dec-17-19 05:05PM  
Dec-05-19 08:00AM  
Nov-22-19 07:09AM  
Nov-13-19 08:01AM  
Nov-04-19 04:01PM  
Nov-01-19 08:31AM  
Oct-30-19 08:20PM  
04:01PM  
Oct-23-19 12:27PM  
Oct-18-19 12:32PM  
Oct-16-19 07:06AM  
Oct-15-19 11:01PM  
04:18PM  
Sep-25-19 07:00AM  
Sep-09-19 07:30AM  
Sep-03-19 08:00AM  
Aug-07-19 10:37AM  
09:49AM  
07:01AM  
Aug-06-19 10:40AM  
Jul-29-19 04:01PM  
08:00AM  
Jul-24-19 08:00AM  
Jul-17-19 04:01PM  
Jul-16-19 10:28AM  
Jun-19-19 04:01PM  
May-30-19 08:00AM  
May-07-19 10:54AM  
08:00AM  
May-03-19 08:36AM  
Apr-26-19 12:13PM  
Apr-02-19 08:00AM  
Apr-01-19 08:00AM  
Mar-28-19 07:00AM  
Mar-08-19 08:12AM  
Mar-04-19 08:00AM  
Feb-07-19 07:55AM  
Jan-25-19 11:03AM  
Jan-04-19 08:00AM  
Dec-13-18 07:00AM  
Dec-06-18 08:00AM  
Nov-15-18 08:00AM  
Nov-09-18 08:00AM  
Nov-07-18 08:00AM  
Oct-17-18 08:15AM  
Oct-15-18 08:00AM  
Sep-28-18 07:00AM  
07:00AM  
Sep-25-18 08:00AM  
Sep-16-18 04:31PM  
Sep-07-18 08:00AM  
Aug-20-18 07:55AM  
Aug-08-18 04:01PM  
Jul-23-18 08:00AM  
Jun-25-18 04:01PM  
Jun-21-18 03:31PM  
Jun-20-18 09:37PM  
Jun-18-18 05:19PM  
07:00AM  
Jun-14-18 08:00AM  
Jun-05-18 07:45AM  
Jun-04-18 09:41AM  
Jun-01-18 08:00AM  
May-31-18 06:45AM  
May-14-18 08:00AM  
May-09-18 04:01PM  
04:01PM  
Apr-11-18 07:40AM  
Apr-02-18 08:00AM  
Mar-19-18 04:01PM  
Mar-15-18 08:15AM  
Mar-12-18 04:01PM  
Mar-07-18 04:01PM  
Jan-09-18 09:00AM  
Jan-04-18 08:00AM  
Nov-14-17 08:00AM  
07:00AM  
Nov-13-17 10:00AM  
Nov-02-17 07:20AM  
Oct-31-17 08:01AM  
Oct-10-17 04:13PM  
04:01PM  
Oct-08-17 08:41AM  
Rhythm Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic disorders. The company's lead product candidate is setmelanotide, a melanocortin-4 receptor, which is in Phase III clinical trials to treat pro-opiomelanocortin (POMC) and leptin receptor deficiency obesity, and Bardet-Biedl and Alstrom syndrome; and is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. It is also developing RM-853, an orally available ghrelin o-acyltransferase inhibitor that is in preclinical development for Prader-Willi syndrome. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RA CAPITAL MANAGEMENT, L.P.10% OwnerJul 02Sale22.0444,153972,9695,140,408Jul 02 04:46 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerJul 01Sale21.8725,527558,3115,184,561Jul 02 04:46 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerJun 30Sale22.1561,9011,371,2375,210,088Jul 02 04:46 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerJun 29Sale22.1952,0491,154,9995,271,989Jun 29 06:31 PM
Foley ToddDirectorJun 26Sale25.043007,5121,909,258Jun 30 04:35 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerJun 26Sale23.3186,7062,020,8485,324,038Jun 29 06:31 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerJun 25Sale25.0511,568289,7685,410,744Jun 29 06:31 PM
Foley ToddDirectorJun 25Sale25.4117,947456,0331,909,558Jun 25 05:38 PM
Foley ToddDirectorJun 24Sale25.3497,3882,467,8121,927,505Jun 25 05:38 PM
Foley ToddDirectorJun 05Sale20.001,89637,9202,024,893Jun 05 04:16 PM
Foley ToddDirectorJun 03Sale20.2718,245369,8262,026,789Jun 03 05:08 PM
Foley ToddDirectorJun 02Sale20.2315,578315,1432,045,034Jun 03 05:08 PM
Foley ToddDirectorJun 01Sale20.0810,535211,5432,060,612Jun 03 05:08 PM
Foley ToddDirectorMay 28Sale20.1919,152386,6792,071,147May 28 06:39 PM
Foley ToddDirectorMay 27Sale20.1310,148204,2792,090,299May 28 06:39 PM
Foley ToddDirectorMay 26Sale20.4744,421909,2982,100,447May 26 05:14 PM
Foley ToddDirectorMay 22Sale20.1326,906541,6182,144,868May 26 05:14 PM
Foley ToddDirectorMay 21Sale20.2525,594518,2792,171,774May 26 05:14 PM
Foley ToddDirectorMay 20Sale20.0110,527210,6452,197,368May 20 05:48 PM
Foley ToddDirectorMay 19Sale20.002,63352,6602,207,895May 20 05:48 PM
Foley ToddDirectorMay 18Sale20.0021,349426,9802,210,528May 20 05:48 PM
Foley ToddDirectorMay 13Sale20.041,83736,8132,231,877May 15 05:59 PM
Foley ToddDirectorMay 12Sale20.2324,342492,4392,233,714May 12 05:28 PM
Foley ToddDirectorMay 11Sale20.3422,155450,6332,258,056May 12 05:28 PM
Foley ToddDirectorMay 08Sale20.056,633132,9922,280,211May 12 05:28 PM
Foley ToddDirectorMay 07Sale20.012004,0022,286,844May 07 05:02 PM
Foley ToddDirectorMay 06Sale20.001,62632,5202,287,044May 07 05:02 PM
Foley ToddDirectorApr 29Sale20.1220,397410,3882,288,670Apr 30 04:45 PM
Foley ToddDirectorApr 28Sale20.0715,826317,6282,309,067Apr 30 04:45 PM
Foley ToddDirectorApr 01Sale15.1015,462233,4762,324,893Apr 01 04:20 PM
Foley ToddDirectorMar 31Sale15.1619,108289,6772,340,355Apr 01 04:20 PM
Smith Hunter CCFO and Interim CEOMar 30Option Exercise6.883,90026,83229,650Mar 31 06:00 PM
Foley ToddDirectorMar 26Sale15.042,30034,5922,359,463Mar 30 04:57 PM
Foley ToddDirectorMar 20Sale15.001,10016,5002,361,763Mar 24 04:58 PM
Foley ToddDirectorMar 19Sale15.078,200123,5742,362,863Mar 19 05:04 PM
Foley ToddDirectorMar 18Sale15.1412,781193,5042,371,063Mar 19 05:04 PM
Foley ToddDirectorMar 17Sale15.129,653145,9532,383,844Mar 19 05:04 PM
Smith Hunter CChief Financial OfficerMar 13Option Exercise6.883,50024,08025,750Mar 16 04:16 PM
Gottesdiener Keith MichaelCEO & PresidentMar 09Option Exercise6.143,40820,925558,250Mar 11 04:01 PM
Gottesdiener Keith MichaelCEO & PresidentFeb 10Option Exercise6.146,81641,850554,283Feb 12 04:00 PM
Smith Hunter CChief Financial OfficerJan 28Option Exercise6.886,25043,00022,250Jan 29 04:00 PM
Gottesdiener Keith MichaelCEO & PresidentJan 08Option Exercise4.5933,072151,800546,914Jan 10 04:01 PM
Desikan NithyaChief Commercial OfficerDec 27Option Exercise6.8835,181242,04564,249Dec 31 04:02 PM
Desikan NithyaChief Commercial OfficerDec 27Sale22.7935,181801,77129,068Dec 31 04:02 PM
Foley ToddDirectorDec 12Sale25.013,76294,0882,393,497Dec 13 04:25 PM
Foley ToddDirectorDec 11Sale25.1413,600341,9042,397,259Dec 13 04:25 PM
Foley ToddDirectorDec 10Sale25.3641,8391,061,0372,410,859Dec 11 04:13 PM
Foley ToddDirectorDec 09Sale25.0422,195555,7632,452,698Dec 11 04:13 PM
Foley ToddDirectorDec 03Sale22.3316,777374,6302,474,893Dec 03 08:05 PM
Foley ToddDirectorDec 02Sale22.0325,366558,8132,491,670Dec 03 08:05 PM
Foley ToddDirectorNov 29Sale22.6718,359416,1992,517,036Nov 29 02:40 PM
Foley ToddDirectorNov 27Sale22.9134,960800,9342,535,395Nov 29 02:40 PM
Foley ToddDirectorNov 26Sale23.3174,2251,730,1852,570,355Nov 29 02:40 PM
Foley ToddDirectorNov 25Sale23.16121,3432,810,8392,644,580Nov 26 04:22 PM
Foley ToddDirectorNov 22Sale21.78102,6822,236,7182,765,923Nov 26 04:22 PM
Foley ToddDirectorNov 21Sale20.5564,9231,334,1412,868,605Nov 22 05:30 PM
Foley ToddDirectorNov 20Sale22.02141,3653,112,8572,933,528Nov 22 05:30 PM